Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10078425 | 0.94 | KIF11 (0.45) | ALDH1A1TSHRSLC6A4 | |
| SCHEMBL20636723 | 0.94 | EPHX2 (0.44) | ALDH1A1TSHRSLC6A4DAOEPHX2 | |
| SCHEMBL508197 | 0.94 | SLC6A4 (0.49) | ALDH1A1TSHRSLC6A4DAOEPHX2 | |
| SCHEMBL508826 | 0.89 | CYP2D6 (0.41) | ALDH1A1TSHRSLC6A4DAOBCHE | |
| SCHEMBL508827 | 0.89 | CYP2D6 (0.41) | ALDH1A1TSHRSLC6A4DAOBCHE | |
| SCHEMBL3051500 | 0.83 | DAO (0.47) | ALDH1A1TSHRSLC6A4DAOEPHX2 | |
| SCHEMBL7762320 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TSHRSLC6A4DAOGPR84 | |
| SCHEMBL4218815 | 0.83 | ALDH1A1 (0.41) | ALDH1A1TSHRSLC6A4EPHX2GRIN2B | |
| SCHEMBL2092054 | 0.81 | SLC6A4 (0.56) | ALDH1A1TSHRSLC6A4DAOEPHX2 | |
| SCHEMBL5753027 | 0.81 | PTGES2 (0.40) | ALDH1A1TSHRSLC6A4MAPTEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1548 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431278-A | Aromatic oxetanes and their use in encapsulation compositions | 华为技术有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119264013-A | Preparation method of (1-arylmethyl-3-aryl-1-trifluoromethyl propyl) aromatic compound | 南京工业大学 | 2025-01-07 | — | — | CN | claimed |
| CN-119101052-A | Matrine-triazole derivative and synthesis method thereof | 吉林医药学院 | 2024-12-10 | — | — | CN | claimed |
| CN-114249747-A | New synthesis process of nitroimidazole pyran medicine for treating wide drug-resistant tuberculosis | 苏州虞美景盛新药开发有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-110483549-B | Preparation method of nitroimidazole pyran antituberculosis drug | 沈阳药科大学 | 2021-03-05 | — | — | CN | claimed |
| CN-107915747-B | Synthetic method of PA-824 | 瑞阳制药股份有限公司 | 2020-11-10 | — | — | CN | claimed |
| JP-4360875-A | — | — | None | — | — | JP | disclosed |
| JP-4264048-A | — | — | None | — | — | JP | disclosed |
| US-12637414-B2 | Arylamides and methods of use thereof | GENZYME CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630498-B2 | Arylamides and methods of use thereof | GENZYME CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| CN-119431371-B | Beta-carbolin 3,6, 9-modified derivative and preparation method and application thereof | 沈阳药科大学 | 2026-05-19 | — | — | CN | disclosed |
| US-12630521-B2 | Arylamides and methods of use thereof | GENZYME CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| CN-122055361-A | Fascin inhibitors | 北京双鹤润创科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| JP-H04264048-A | TRIFLUOROMETHYL COMPOUND | CHISSO CORP | 1992-09-18 | — | — | JP | disclosed |
| EP-0442306-A2 | (4E-cyclohexyl-3-butenyl)phenyl derivatives | F. Hoffmann-La Roche AG (CH) | 1991-08-21 | — | — | EP | disclosed |
| US-5006543-A | Diphenylethane derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-04-09 | — | — | US | disclosed |
| EP-0354689-A1 | Diphenylethane derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-02-14 | — | — | EP | disclosed |
| EP-0008854-B1 | PENTADIENONE HYDRAZONE, AND ITS USE AS INSECTICIDAL AGENT | AMERICAN CYANAMID COMPANY (US) | 1983-03-09 | — | — | EP | disclosed |
| EP-0008854-A1 | Pentadienone hydrazone, and its use as insecticidal agent | AMERICAN CYANAMID COMPANY (US) | 1980-03-19 | — | — | EP | disclosed |
| US-4191768-A | Pentadienone hydrazones, method for preparing the same, and insecticidal use thereof | AMERICAN CYANAMID COMPANY (US) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637414-B2 | Arylamides and methods of use thereof | CFTR, CLIC1, ABCC1 | ALDH1A1 630/4885TSHR 715/4885SLC6A4 816/4885 |
| US-12630521-B2 | Arylamides and methods of use thereof | CFTR, CLIC1, CLCN2 | ALDH1A1 905/4885TSHR 497/4885SLC6A4 942/4885 |
| US-12630498-B2 | Arylamides and methods of use thereof | CFTR, CLIC1, CLCN2 | ALDH1A1 775/4885TSHR 337/4885SLC6A4 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.